History

How the Story Changed

AMD's history is an eleven-year arc with the same CEO. Lisa Su took the seat in October 2014 with the company on its hospital bed — three losing CEOs in six years, $2.5B in debt, revenue collapsing, stock near $3. Eleven years later AMD is a $34.6B-revenue, ~50%-gross-margin AI infrastructure company shipping a 6-gigawatt deal with OpenAI and a 6-gigawatt deal with Meta. Nothing on this page was inherited — every revenue, margin, and credibility point was built under the current team. The narrative shift since FY2021 matters: management has executed every near-term commitment of consequence but has steadily replaced precise dollar guides with multi-year aspirational framing as the stakes have grown.

The Decade in One Chart

Three discrete chapters live inside one CEO tenure: a near-death triage (2014–2016), the Zen-led rebuild (2017–2021), and the post-Xilinx pivot into AI infrastructure (2022 onward — accelerating sharply from late 2023). The current strategic chapter — Instinct/Helios as a top-line AI franchise — really starts the day MI300 ships in volume in late 2023 and is fully formed by the OpenAI announcement in October 2025.

Chapter 1 — The Hospital Bed (2014–2016)

The business Lisa Su inherited was failing on every dimension. Revenue fell from $5.5B in FY2014 to $3.99B in FY2015. Gross margin collapsed to 23–27%. Operating losses totaled roughly $1B across 2014–2016. The PC business was being gutted by Intel; the server share was rounding to zero; the foundry (GlobalFoundries) had been spun off in 2008; and the company carried $2.5B of legacy debt against a stock the market had nearly written off.

This chapter sets the bar for everything that follows: the business was unambiguously not high-quality when current leadership arrived. Every share gain, every margin point, every AI dollar today was built — not inherited. That fact governs how the rest of the page should be read, and it governs the capital-allocation thesis the Long-Term view will build on.

Chapter 2 — Zen Earns Trust Back (2017–2021)

The Zen architecture, taped out under Mark Papermaster and Lisa Su's leadership, broke cover with Ryzen (consumer CPU) in March 2017 and EPYC (server CPU) in June 2017. The financials inflect immediately: FY2017 returns to operating profit, FY2018 doubles operating income, FY2019 launches Zen 2 on TSMC's 7nm — overtaking Intel's process node for the first time in AMD's history — and FY2021 closes with revenue up +199% over FY2014 and operating income at $3.65B.

The credibility built in this period is the foundation everything since rests on. Su's original turnaround promise — a competitive x86 architecture, a path back to server share, and a return to gross margins above 45% — was delivered in full by 2021. No serial-promiser ever recovered from a five-year run that good. The bar for what investors will take on faith today was earned here.

Chapter 3 — Xilinx, Pensando, and the Wait for AI (2022–2024)

The post-Zen chapter is harder to read cleanly because two stories run at once: a successful diversification on paper (Xilinx closed Feb 2022 for $49B in stock, Pensando May 2022 for $1.9B in cash, Silo AI Aug 2024) and a brutal cyclical drawdown in three of four segments. Embedded — the Xilinx franchise — fell roughly 33% in FY2024 versus FY2022; Gaming peaked in FY2022 and was down 58% by FY2024; Client wobbled with the PC inventory unwind in late 2022. Operating income compressed from $3.65B (FY2021) to $0.40B (FY2023) before the AI franchise lit up.

What carried the chapter was MI300. The hyperscaler design wins were already disclosed in the FY2023 10-K — "large hyperscaler customers committed to deploy" the MI300 — and by Q2 FY2024 Data Center GPU revenue cleared $1B in a single quarter. Management raised the FY2024 Data Center GPU dollar guide three times in three quarters: $4B → $4.5B → $5B+, and delivered every raise.

Less clean: the embedded recovery promise. In Q2 FY2024, Lisa Su called Q1 "the bottom" and promised "gradual recovery" in the second half. Embedded did not turn positive year-over-year until Q4 FY2025 — six quarters later than the implied turn. Investors gave the embedded miss a pass because the AI franchise was hauling everything. But it is the cleanest example in the dataset of management optimism unpunished only because something bigger went right.

Chapter 4 — The AI Infrastructure Pivot (2025– )

The story that is now central to AMD did not exist in this form even a year ago. Three things happened in 2025 that re-cast the company:

1. The dollar guide was retired. Starting with the Q4 FY2024 call (Feb 2025), management stopped giving a specific Data Center GPU revenue number for the year. The new framing is "from more than $5 billion in 2024 to tens of billions of dollars of annual revenue over the coming years." Analysts pushed back hard — Vivek Arya called it out directly. Management held the line and replaced the dollar with a 60%+ data center CAGR and a $500B 2028 accelerator TAM.

2. The MI308/China shock — and the reserve reversal. A new April 2025 export control restriction killed MI308 sales to China, triggering an $800M inventory and related charge in Q2 FY2025 (gross margin fell to 43% headline). Then in Q4 FY2025, licenses were partially granted; $390M of MI308 shipped and AMD released $306M of the inventory reserve as a margin tailwind. Net of the reserve release and China revenue, Q4 FY2025 gross margin would have been ~55%; reported was 57%. The handling was technically transparent but commercially opportunistic — a credibility-neutral episode.

3. OpenAI and Meta. In October 2025 AMD announced a 6-gigawatt Instinct deployment with OpenAI ("well over $100 billion in revenue over the next few years"), backed by an OpenAI warrant for up to 160M shares at $0.01 strike vesting on purchase milestones and AMD stock-price targets. Then in the Q1 FY2026 call AMD announced a second 6-gigawatt Meta deal spanning multiple Instinct generations. The "tens of billions" gets a year attached: 2027. The CPU TAM is revised from $60B to $120B by 2030.

Narrative Drift — What Management Stopped Saying

The strongest evidence of how the story has shifted is what's no longer in the disclosure language. Reading the 10-K risk factors across FY2021–FY2025 in sequence, the lead risk silently changes from "Intel" to "Nvidia"; COVID disappears entirely after FY2023; CHIPS Act competitive disadvantage appears in FY2023 and is gone by FY2025; and an entirely new cluster of risks — China export controls, AI customer concentration, AI customer ability to secure capital and energy for data-center buildout — moves to the top of the deck.

The heatmap reads like a chip-stack diagram of the company's evolving worldview. The Xilinx integration story has been quietly absorbed (the phrase "Xilinx synergies" effectively disappeared from earnings calls after Q1 FY2025; the products are now pitched on their own merits as Versal / Alveo). The Pensando "DPU synergy" pitch is similarly gone. The Silo AI acquisition (Q3 FY2024) is barely named after one quarter. Meanwhile Helios — a brand that did not exist in any disclosure before Q2 FY2025 — is now the dominant data center framing in five quarters flat. That speed of brand consolidation is unusual and is a positive credibility signal: management names things and ships, rather than naming things and forgetting them.

What also changed: management has stopped using the word "discipline" and started using the word "opportunity" in capital-allocation language. The buyback authorization was expanded to $14 billion in late 2025 and the pace of repurchase doubled in FY2025 — coupled with the OpenAI warrant and $12.2B of unconditional purchase commitments (multi-year cloud capacity), capital deployment has shifted decisively from defensive to offensive.

The Promise / Delivery Track Record

The receipts that matter. Each row is a specific, valuation-relevant promise — large enough that a buy-side reader can verify it.

The headline ratio on decided promises is 6 of 10 cleanly kept, but the texture matters more than the count. Every miss has a common pattern: management was optimistic about a recovery timing (embedded soft landing, H1 2025 DC, China MI308) and conservative about a core product ramp (Zen, EPYC share, MI300 GPU dollars, MI350 schedule). The product ramps have been delivered every time. The cyclical recoveries have run late, every time. Bet on what AMD builds; don't bet on what AMD says about end-market timing.

Credibility Verdict

Score: 8 / 10. The verdict rests on three asymmetric pieces of evidence:

• The base rate is exceptional. Lisa Su delivered the most successful CPU architecture comeback in semiconductor history. Revenue ~6x, gross margin ~45 percentage points off the trough, debt-to-EBITDA collapse from distressed to investment grade. This is not a young narrative looking for trust — it is an eleven-year compounder of credibility.

• The retail-grade misses are honest. The embedded "gradual recovery" promise was kept reframing itself for six quarters with no excuses; the MI308 China handling included a transparent $800M write-down before any later reserve release; the H1 2025 DC "consistency" promise was acknowledged as broken by the export-control story rather than spun away.

• The risk is forward, not backward. The 2027 "tens of billions," the >60% DC CAGR, the $120B 2030 CPU TAM, and the OpenAI/Meta gigawatt deals are the largest concentrated set of forward commitments in the company's history. None can be checked yet. The dollar-guide retirement after Q4 FY2024 was a deliberate choice to trade quarterly accountability for narrative flexibility — a signal that management is now in capture mode on the upside and does not want to be boxed in by a number. Worth watching.

What to Believe vs. Discount

Believe:

• The company can build product. Annual cadence promises (MI300 → MI325 → MI350 → MI355X → MI400 → MI500) have been hit or pulled forward, never slipped. Helios is real because ZT Systems is real and the rack ships in 2H 2026.
• The OpenAI and Meta gigawatt commitments are anchored in actual purchase contracts and (in OpenAI's case) a vesting warrant — not slideware.
• Gross margins above 50% are now structural, not cyclical: mix is moving toward Data Center every quarter.

Discount:

• The "tens of billions in 2027" framing is aspirational until the first MI450 gigawatt deploys in 2H 2026 and the first OpenAI revenue prints. Until then it is a target, not a number.
• Cyclical recovery timing (embedded, gaming, semi-custom). The Q4 FY2025 call already warned of "seventh year of console cycle" and double-digit semi-custom decline expected in 2026. Embedded design wins (now $50B+ since the acquisition) are real but conversion has consistently lagged.
• The MI308 China line — small but volatile and increasingly political; MI325 China licenses are now in the application pipeline and the outcome is unknowable.
• "AI customer power / capital risk" is now a top-five risk factor in the 10-K. That is unusual language for a supplier — it is an implicit acknowledgement that hyperscaler buying power and AI-customer financing capacity could become the binding constraint, not GPU supply.

The story today is simpler than the diversification chapter of 2022–2023 and more stretched than the Zen chapter of 2017–2021. It is essentially one bet — that AMD is the credible second source in AI infrastructure, with a CPU franchise underneath that funds the bet. The credibility built over the prior decade is the reason a $300B+ market capitalization will take that bet at face value. The credibility built over the prior decade is also exactly what would be at risk if 2027 disappoints. That asymmetry is the central feature of the AMD story now.